In this study, we demonstrated for the first time that the desmosomal component Dsg2 played a tumor-suppressive role in GBC cells, as its loss-induced key biological activities of cells, including proliferation, motility, invasion, and transendothelial migration in vitro, as well as GBC tumor growth and metastasis in vivo. This evidence concerns the gene DSG2 and neoplasm.